These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11262110)

  • 1. Cyclopropane-derived peptidomimetics. design, synthesis, and evaluation of novel Ras farnesyltransferase inhibitors.
    Hillier MC; Davidson JP; Martin SF
    J Org Chem; 2001 Mar; 66(5):1657-71. PubMed ID: 11262110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
    Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
    J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors.
    Martin SF; Dorsey GO; Gane T; Hillier MC; Kessler H; Baur M; Mathä B; Erickson JW; Bhat TN; Munshi S; Gulnik SV; Topol IA
    J Med Chem; 1998 May; 41(10):1581-97. PubMed ID: 9572884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3-trisubstituted cyclopropanes as conformationally restricted peptide isosteres: application to the design and synthesis of novel renin inhibitors.
    Martin SF; Austin RE; Oalmann CJ; Baker WR; Condon SL; deLara E; Rosenberg SH; Spina KP; Stein HH; Cohen J
    J Med Chem; 1992 May; 35(10):1710-21. PubMed ID: 1588553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and properties of cyclopropane-derived peptidomimetics.
    Reichelt A; Martin SF
    Acc Chem Res; 2006 Jul; 39(7):433-42. PubMed ID: 16846207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.
    Henry KJ; Wasicak J; Tasker AS; Cohen J; Ewing P; Mitten M; Larsen JJ; Kalvin DM; Swenson R; Ng SC; Saeed B; Cherian S; Sham H; Rosenberg SH
    J Med Chem; 1999 Nov; 42(23):4844-52. PubMed ID: 10579847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding.
    Davidson JP; Lubman O; Rose T; Waksman G; Martin SF
    J Am Chem Soc; 2002 Jan; 124(2):205-15. PubMed ID: 11782172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of potent nonpeptidic farnesyltransferase inhibitors based on a terphenyl scaffold.
    Ohkanda J; Lockman JW; Kothare MA; Qian Y; Blaskovich MA; Sebti SM; Hamilton AD
    J Med Chem; 2002 Jan; 45(1):177-88. PubMed ID: 11754590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing.
    Vogt A; Qian Y; Blaskovich MA; Fossum RD; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Jan; 270(2):660-4. PubMed ID: 7822292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclopropane-derived peptidomimetics. Design, synthesis, and evaluation of novel enkephalin analogues.
    Martin SF; Dwyer MP; Hartmann B; Knight KS
    J Org Chem; 2000 Mar; 65(5):1305-18. PubMed ID: 10814090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and conformational analysis of peptide inhibitors of farnesyltransferase.
    Byk G; Lelievre Y; Duchesne M; Clerc FF; Scherman D; Guitton JD
    Bioorg Med Chem; 1997 Jan; 5(1):115-24. PubMed ID: 9043663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of homofarnesoyl-substituted CAAX-peptidomimetics as farnesyltransferase inhibitors and antiproliferative agents.
    Schlitzer M; Sattler I; Dahse HM
    Bioorg Med Chem; 1999 Sep; 7(9):2037-45. PubMed ID: 10530953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors.
    Qian Y; Vogt A; Sebti SM; Hamilton AD
    J Med Chem; 1996 Jan; 39(1):217-23. PubMed ID: 8568811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferase.
    Qian Y; Blaskovich MA; Saleem M; Seong CM; Wathen SP; Hamilton AD; Sebti SM
    J Biol Chem; 1994 Apr; 269(17):12410-3. PubMed ID: 8175645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of hydroxyproline-derived isoprenyltransferase inhibitors.
    O'Connell CE; Ackermann K; Rowell CA; Garcia AM; Lewis MD; Schwartz CE
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2095-100. PubMed ID: 10450988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel class of highly potent, selective, and non-peptidic inhibitor of Ras farnesyltransferase (FTase).
    Lee H; Lee J; Lee S; Shin Y; Jung W; Kim JH; Park K; Kim K; Cho HS; Ro S; Lee S; Jeong SW; Choi T; Chung HH; Koh JS
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3069-72. PubMed ID: 11714612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of potential bisubstrate inhibitors of protein farnesyltransferase. Design and synthesis of functionalized imidazoles.
    de Figueiredo RM; Coudray L; Dubois J
    Org Biomol Chem; 2007 Oct; 5(20):3299-309. PubMed ID: 17912382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
    Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
    Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.